Home Cart 0 Sign in  
X

[ CAS No. 3034-50-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 3034-50-2
Chemical Structure| 3034-50-2
Chemical Structure| 3034-50-2
Structure of 3034-50-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 3034-50-2 ]

Related Doc. of [ 3034-50-2 ]

Alternatived Products of [ 3034-50-2 ]

Product Details of [ 3034-50-2 ]

CAS No. :3034-50-2 MDL No. :MFCD00173726
Formula : C4H4N2O Boiling Point : -
Linear Structure Formula :- InChI Key :ZQEXIXXJFSQPNA-UHFFFAOYSA-N
M.W : 96.09 Pubchem ID :76428
Synonyms :

Calculated chemistry of [ 3034-50-2 ]

Physicochemical Properties

Num. heavy atoms : 7
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 23.98
TPSA : 45.75 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.99 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.06
Log Po/w (XLOGP3) : -0.14
Log Po/w (WLOGP) : 0.22
Log Po/w (MLOGP) : -1.44
Log Po/w (SILICOS-IT) : 1.2
Consensus Log Po/w : -0.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -0.81
Solubility : 14.9 mg/ml ; 0.155 mol/l
Class : Very soluble
Log S (Ali) : -0.37
Solubility : 41.3 mg/ml ; 0.43 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.1
Solubility : 7.69 mg/ml ; 0.08 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 3034-50-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 3034-50-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 3034-50-2 ]
  • Downstream synthetic route of [ 3034-50-2 ]

[ 3034-50-2 ] Synthesis Path-Upstream   1~31

  • 1
  • [ 67-56-1 ]
  • [ 3034-50-2 ]
  • [ 17325-26-7 ]
YieldReaction ConditionsOperation in experiment
40%
Stage #1: for 0.25 h; Green chemistry
Stage #2: With tert.-butylhydroperoxide In decane for 48 h; Green chemistry
General procedure: B(C6F5)3 (1 mol percent) was added to a stirringsolution of aldehyde (1 mmol) in MeOH (6 mL). After 15 min., 5.5 M TBHP indecane (3 mmol) was added slowly and reaction mixture was refluxed untilthe complete conversion of starting material (monitored by TLC). Aftercompletion of reaction, the methanol was evaporated in vacuo. Later, thereaction mixture was diluted with water (20 mL) and extracted with ethylacetate (3 15 mL). The organic layer was washed with cold saturated sodiumbicarbonate solution (2 20 mL) followed by brine. The organic layer wasdried over MgSO4 and concentrated under reduced pressure and products werepurified over silica gel column chromatography in ethyl acetate/hexane. Allcompounds were characterized and confirmed by comparison of their spectraldata and physical properties with reported literature.
Reference: [1] Tetrahedron Letters, 2015, vol. 56, # 7, p. 889 - 892
  • 2
  • [ 3034-50-2 ]
  • [ 15813-09-9 ]
Reference: [1] Advanced Synthesis and Catalysis, 2013, vol. 355, # 2-3, p. 499 - 507
  • 3
  • [ 2302-25-2 ]
  • [ 68-12-2 ]
  • [ 3034-50-2 ]
YieldReaction ConditionsOperation in experiment
85%
Stage #1: With isopropylmagnesium chloride In tetrahydrofuran at 0℃; for 0.166667 h;
Stage #2: With n-butyllithium In tetrahydrofuran; hexane at -20℃; for 0.5 h;
Stage #3: at -20℃; for 0.5 h;
To a solution of 4-bromo-1H-imidazole (0.65 g, 4.4 mmol, 1.0 equiv.) indry THF (20 mL) at 0 C was added a 2 M solution of i-PrMgCl in THF (2.2 mL, 4.4 mmol, 1.0 equiv.)during 5 min. The clear solution was stirred at that temperature for an additional 5 min, and a2.5 M solution of n-BuLi in hexanes (3.5 mL, 8.8 mmol, 2.0 equiv.) was added dropwise during5 min, while maintaining the temperature below 20 C. The resulting mixture was stirred at thattemperature for 0.5 h, dry DMF (0.32 g, 4.4 mmol, 1.0 equiv.) was added to 20 C. The resultingmixture was warmed to 20 C in 0.5 h and quenched with water (6 mL). After stirring the mixturebelow 20 C for 10 min, the phases were separated and the water phase was extracted one additionaltime with ethyl acetate. The resulting suspension was allowed to reach room temperature and ®teredthrough a 0.5 1 cm pad of silica gel eluted with 10 mL of ethyl acetate. The ®ltrate was concentratedand the residue was puri®ed by ash chromatography on silica gel (eluent:petroleum ether/ethylacetate = 10:1) to afford product 3l as off-white solid, 0.36 g (yield: 85percent), m.p.: 175–177 C. 1H-NMR(600 MHz, DMSO) 9.74 (s, 1H), 7.99 (s, 1H), 7.94 (s, 1H). 13C-NMR (151 MHz, DMSO) 184.46, 139.44,134.9, 129.5.
Reference: [1] Molecules, 2017, vol. 22, # 11,
  • 4
  • [ 2644-71-5 ]
  • [ 3034-50-2 ]
YieldReaction ConditionsOperation in experiment
54% With sodium periodate In water at 27 - 30℃; for 2 h; Reference Example 10Under nitrogen stream, to ( 1R, 2S, 3R) -1- (2-sulfanyl-lH- imidazol-4-yl) butane-1, 2, 3, 4-tetraol (10 g, 45.4 mmol) was added water (40 mL) , and to the obtained suspension was added dropwise an aqueous diluted solution- of 30percent aqueous hydrogen peroxide (15.4 g, 136 mmol, 3.0 equivalents) in water (40 mL) over 10 min at 17 to 43°C (the compound was gradually dissolved to give an uniform pale-yellow solution) . The reaction mixture was stirred at 24 to 36°C for 4 hr, and barium carbonate (27 g, 136 mmol, 3.0 equivalents) was added over 5 min at 24 to 26°C (neutralized to pH 7), and the mixture was stirred at 25 to26°C for 1 hr and 20 min. The insoluble material was filtered off, and washed with water (40 mL) . To the filtrate and washing was added sodium sulfite (11.4 g, 90.8 mmol, 2.0 equivalents) over 5 min at 20 to 32°C. The obtained aqueous solution was stirred at 26 to 32°C for 1 hr and 30 min to give an aqueous solution of (1R, 2S, 3R) -1- (lH-imidazol-4-yl) butane- 1 , 2 , 3 , 4-tetraol . To this aqueous solution was added sodium periodate (29.1 g, 136 mmol, 3.0 equivalents) over 10 min at 12 to 30°C, and the mixture was stirred at 27 to 30°C for 1 hr and 30 min. To the reaction mixture was added sodium periodate(2.91 g, 13.6 mmol, 0.3 equivalents) at 27 to 30°C, and the mixture was stirred at 27 to 30°C for 2 hr. The insoluble material was filtered off, and washed four times with water (10 mL) . To the filtrate and washing was added methanol (500 mL) , and the inorganic salt was filtered off, and washed twice with methanol (50 mL) . To the filtrate and washing was added activated carbon (3 g, SHIRASAGI A, trade name), and the mixture was stirred at room temperature for 1 hr. Theinsoluble material was filtered off, and washed with methanol. The filtrate and washing were concentrated under reduced pressure to give a crude compound (9.37 g) . To the crude compound were added water (3 mL) and seed crystals forcrystallization, and the mixture was stirred at roomtemperature for 24 hr, and then for 2 hr under ice-cooling. The crystals were collected by filtration-, washed with cooled water (1 mL) , and vacuum-dried (50°C) to a constant amount to give (5) -formylimidazole (2.35 g) . yield 54percent.
Reference: [1] Patent: WO2012/173280, 2012, A1, . Location in patent: Page/Page column 34-35
  • 5
  • [ 822-55-9 ]
  • [ 3034-50-2 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 11, p. 3364 - 3368
[2] RSC Advances, 2014, vol. 4, # 76, p. 40561 - 40568
[3] Journal of the Chemical Society. Perkin transactions 1, 1980, vol. 1, p. 43 - 51
[4] Tetrahedron Letters, 1994, vol. 35, # 28, p. 4903 - 4906
[5] Collection of Czechoslovak Chemical Communications, 2002, vol. 67, # 9, p. 1335 - 1344
  • 6
  • [ 822-36-6 ]
  • [ 3034-50-2 ]
Reference: [1] Patent: CN107954938, 2018, A, . Location in patent: Paragraph 0021; 0028; 0035; 0042; 0049
  • 7
  • [ 32673-41-9 ]
  • [ 3034-50-2 ]
Reference: [1] Synthetic Communications, 2000, vol. 30, # 18, p. 3383 - 3389
[2] Patent: EP1196129, 2005, B1, . Location in patent: Page/Page column 8
  • 8
  • [ 288-32-4 ]
  • [ 822-55-9 ]
  • [ 3034-50-2 ]
Reference: [1] Patent: US4977174, 1990, A,
  • 9
  • [ 33016-47-6 ]
  • [ 3034-50-2 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1985, vol. 22, p. 57 - 59
[2] Tetrahedron, 1992, vol. 48, # 21, p. 4327 - 4346
  • 10
  • [ 1025907-10-1 ]
  • [ 3034-50-2 ]
Reference: [1] Synthesis, 1994, # 3, p. 245 - 246
  • 11
  • [ 3465-72-3 ]
  • [ 645-65-8 ]
  • [ 3034-50-2 ]
  • [ 1072-84-0 ]
Reference: [1] Patent: EP1196129, 2005, B1, . Location in patent: Page/Page column 5; 14; 15; 22
[2] Patent: EP1196129, 2005, B1, . Location in patent: Page/Page column 5; 14; 15; 22
  • 12
  • [ 340699-23-2 ]
  • [ 3034-50-2 ]
Reference: [1] Organic Mass Spectrometry, 1986, vol. 21, p. 499 - 506
  • 13
  • [ 3465-72-3 ]
  • [ 645-65-8 ]
  • [ 3034-50-2 ]
  • [ 1072-84-0 ]
  • [ 7699-35-6 ]
Reference: [1] Patent: EP1196129, 2005, B1, . Location in patent: Page/Page column 4; 5; 7; 8; 21; 22
  • 14
  • [ 3465-72-3 ]
  • [ 3034-50-2 ]
Reference: [1] Tetrahedron Letters, 1994, vol. 35, # 28, p. 4903 - 4906
  • 15
  • [ 67242-59-5 ]
  • [ 3034-50-2 ]
Reference: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 2004, vol. 47, # 14, p. 1039 - 1040
  • 16
  • [ 3034-50-2 ]
  • [ 1072-84-0 ]
Reference: [1] Patent: CN107954938, 2018, A, . Location in patent: Paragraph 0022; 0029; 0036; 0043; 0050
  • 17
  • [ 3465-72-3 ]
  • [ 645-65-8 ]
  • [ 3034-50-2 ]
  • [ 1072-84-0 ]
Reference: [1] Patent: EP1196129, 2005, B1, . Location in patent: Page/Page column 5; 14; 15; 22
[2] Patent: EP1196129, 2005, B1, . Location in patent: Page/Page column 5; 14; 15; 22
  • 18
  • [ 3465-72-3 ]
  • [ 645-65-8 ]
  • [ 3034-50-2 ]
  • [ 1072-84-0 ]
  • [ 7699-35-6 ]
Reference: [1] Patent: EP1196129, 2005, B1, . Location in patent: Page/Page column 4; 5; 7; 8; 21; 22
  • 19
  • [ 3034-50-2 ]
  • [ 57090-88-7 ]
YieldReaction ConditionsOperation in experiment
82%
Stage #1: at 8 - 30℃; for 2 h;
Stage #2: at 80 - 110℃; for 3.83333 h;
Example 72An alternate method'for the synthesis of the imidazole intermediate is described below:4-Cyano-l-(2-trimethylsilanyl-ethoxymethyl)-lH-imidazole-2-carboxylic acid potassium salt a) lH-Imidazole-4-carbonitrile; '-NHA 22-L, four-neck, round-bottom flask equipped with a mechanical stirrer, a temperature probe, a condenser, and an addition funnel with a nitrogen inlet was charged with lH-imidazole-4-carboxaldehyde (Aldrich, 1.10 kg, 11.5 mol) and pyridine (3.0 L, 3.0 mol). The reaction flask was cooled to 8 0C with an ice bath and hydroxylamine hydrochloride (871 g, 12.5 mol) was added slowly in portions to maintain the internal temperature below 30 °C. The reaction was allowed to cool to ambient temperature and stirred for 2 h at ambient temperature. The resulting thick yellow solution was heated to 80 0C with a heating mantle and acetic anhydride (2.04 L, 21.6 mol) was added dropwise EPO <DP n="148"/>over 200 min to maintain the temperature below 110 °C during the addition. The reaction mixture was heated at 100 0C for 30 min, after which time it was allowed to cool to ambient temperature and then further cooled in an ice bath. The pH was adjusted to 8.0 (pH meter) by the addition of 25 wt percent NaOH (5.5 L) at such a rate that the internal temperature was maintained below 30 °C. The reaction mixture was then transferred into a 22-L separatory funnel and extracted with ethyl acetate (6.0 L). The combined organic layer was washed with brine (2 x 4.0 L), dried over MgSO4, filtered, and concentrated to dryness under reduced pressure at 35 °C to give the crude product as a yellow semisolid. The resulting semisolid was suspended in toluene (3.0 L) and stirred for 1 h, after which time it was filtered to give a light yellow solid, which was resuspended in toluene (3.0 L) and stirred for 1 h. The resulting slurry was filtered and the filter cake washed with toluene (2 x 500 mL) to give the title compound as a light yellow solid [870 g, 82percent). The 1H and 13C NMR spectra were consistent with the assigned structure.
82% at 0 - 110℃; for 5.83333 h; A 22-L, four-neck, round-bottom flask equipped with a mechanical stirrer, a temperature probe, a condenser, and an addition funnel with a nitrogen inlet was charged with 1H-imidazole-4-carboxaldehyde (Aldrich, 1.10 kg, 11.5 mol) and pyridine (3.0 L, 3.0 mol). The reaction flask was cooled to 8° C. with an ice bath and hydroxylamine hydrochloride (871 g, 12.5 mol) was added slowly in portions to maintain the internal temperature below 30° C. The reaction was allowed to cool to ambient temperature and stirred for 2 h at ambient temperature. The resulting thick yellow solution was heated to 80° C. with a heating mantle and acetic anhydride (2.04 L, 21.6 mol) was added dropwise over 200 min to maintain the temperature below 110° C. during the addition. The reaction mixture was heated at 100° C. for 30 min, after which time it was allowed to cool to ambient temperature and then further cooled in an ice bath. The pH was adjusted to 8.0 (pH meter) by the addition of 25 wt percent NaOH (5.5 L) at such a rate that the internal temperature was maintained below 30° C. The reaction mixture was then transferred into a 22-L separatory funnel and extracted with ethyl acetate (6.0 L). The combined organic layer was washed with brine (2.x.4.0 L), dried over MgSO4, filtered, and concentrated to dryness under reduced pressure at 35° C. to give the crude product as a yellow semisolid. The resulting semisolid was suspended in toluene (3.0 L) and stirred for 1 h, after which time it was filtered to give a light yellow solid, which was resuspended in toluene (3.0 L) and stirred for 1 h. The resulting slurry was filtered and the filter cake washed with toluene (2.x.500 mL) to give the title compound as a light yellow solid [870 g, 82percent). The 1H and 13C NMR spectra were consistent with the assigned structure.
82%
Stage #1: at 8 - 30℃; for 2 h;
Stage #2: at 80 - 110℃; for 0.5 h;
a)
1H-Imidazole-4-carbonitrile
A 22-L, four-neck, round-bottom flask equipped with a mechanical stirrer, a temperature probe, a condenser, and an addition funnel with a nitrogen inlet was charged with 1H-imidazole-4-carboxaldehyde (Aldrich, 1.10 kg, 11.5 mol) and pyridine (3.0 L, 3.0 mol).
The reaction flask was cooled to 8° C. with an ice bath and hydroxylamine hydrochloride (871 g, 12.5 mol) was added slowly in portions to maintain the internal temperature below 30° C.
The reaction was allowed to cool to ambient temperature and stirred for 2 h at ambient temperature.
The resulting thick yellow solution was heated to 80° C. with a heating mantle and acetic anhydride (2.04 L, 21.6 mol) was added dropwise over 200 min to maintain the temperature below 110° C. during the addition.
The reaction mixture was heated at 100° C. for 30 min, after which time it was allowed to cool to ambient temperature and then further cooled in an ice bath.
The pH was adjusted to 8.0 (pH meter) by the addition of 25 wt percent NaOH (5.5 L) at such a rate that the internal temperature was maintained below 30° C.
The reaction mixture was then transferred into a 22-L separatory funnel and extracted with ethyl acetate (6.0 L).
The combined organic layer was washed with brine (2*4.0 L), dried over MgSO4, filtered, and concentrated to dryness under reduced pressure at 35° C. to give the crude product as a yellow semisolid.
The resulting semisolid was suspended in toluene (3.0 L) and stirred for 1 h, after which time it was filtered to give a light yellow solid, which was resuspended in toluene (3.0 L) and stirred for 1 h.
The resulting slurry was filtered and the filter cake washed with toluene (2*500 mL) to give the title compound as a light yellow solid [870 g, 82percent).
The 1H and 13C NMR spectra were consistent with the assigned structure.
82%
Stage #1: With hydroxylamine hydrochloride In pyridine at 8 - 30℃; for 2 h;
Stage #2: at 0 - 110℃; for 0.5 h;
A 22-L, four-neck, round-bottom flask equipped with a mechanical stirrer, a temperature probe, a condenser, and an addition funnel with a nitrogen inlet was charged with lH-imidazole-4-carboxaldehyde (Aldrich, 1.10 kg, 11.5 mol) and pyridine (3.0 L, 3.0 mol). The reaction flask was cooled to 8 0C with an ice bath and hydroxylamine hydrochloride (871 g, 12.5 mol) was added slowly in portions to maintain the internal temperature below 30 0C. The reaction was allowed to cool to ambient temperature and stirred for 2 h at ambient temperature. The resulting thick yellow solution was heated to 80 0C with a heating mantle and acetic anhydride (2.04 L5 21.6 mol) was added dropwise over 200 min to maintain the temperature below 110 0C during the addition. The reaction mixture was heated at 100 0C for 30 min, after which time it was allowed to cool to ambient temperature and then further <n="149"/>cooled in an ice bath. The pH was adjusted to 8.0 (pH meter) by the addition of 25 wt percent NaOH (5.5 L) at such a rate that the internal temperature was maintained below 30 °C. The reaction mixture was then transferred into a 22-L separatory funnel and extracted with ethyl acetate (6.0 L). The combined organic layer was washed with brine (2 x 4.0 L), dried over MgSO4, filtered, and concentrated to dryness under reduced pressure at 35 0C to give the crude product as a yellow semisolid. The resulting semisolid was suspended in toluene (3.0 L) and stirred for 1 h, after which time it was filtered to give a light yellow solid, which was resuspended in toluene (3.0 L) and stirred for 1 h. The resulting slurry was filtered and the filter cake washed with toluene (2 x 500 nxL) to give the title compound as a light yellow solid [870 g, 82percent). The 1H and 13C NMR spectra were consistent with the assigned structure.

Reference: [1] Patent: WO2006/47504, 2006, A1, . Location in patent: Page/Page column 146-147
[2] Patent: US2006/281788, 2006, A1, . Location in patent: Page/Page column 88-89
[3] Patent: US2008/51402, 2008, A1, . Location in patent: Page/Page column 74-75
[4] Patent: WO2007/48088, 2007, A2, . Location in patent: Page/Page column 146-147
[5] Synthesis, 2008, # 21, p. 3377 - 3379
  • 20
  • [ 3034-50-2 ]
  • [ 50743-01-6 ]
YieldReaction ConditionsOperation in experiment
26% With bromine; sodium acetate; acetic anhydride In acetic acid at 20℃; for 3.5 h; Bromine (8.0 g, 50 mmol, 2.3 eq) in anhydrous Ac2O (40 mL) was added dropwise to a solution of 1B (2.08 g, 21.7 mmol) and NaOAc (18.7 g, 228 mmol, 10.5 eq) in anhydrous HOAc (200 mL) over a period of 1 h at RT. The resulting mixture was stirred at RT for 2.5 h and then concentrated. The residue was partitioned between Et2O (200 mL) and water (200 mL), the layers were separated and the aqueous layer was extracted with Et2O (200 mL). The combined organic phase was dried, concentrated and chromatographed (EtOAc) to afford 5-bromo-4-formyl imidazole 39A (1.00 g, 26percent) as white crystals.
Reference: [1] Patent: US2007/93477, 2007, A1, . Location in patent: Page/Page column 44
  • 21
  • [ 3034-50-2 ]
  • [ 74-88-4 ]
  • [ 17289-26-8 ]
YieldReaction ConditionsOperation in experiment
99%
Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at -78 - 20℃; for 0.166667 h; Inert atmosphere
Stage #2: at -78 - 20℃; for 18 h; Inert atmosphere
To a suspension of 10 (4.94 g, 51.4 mmol) in dry THF (30 mL) was added NaH (2.48 g, assey 60percent, 61.9mmol, 1.2 eq) at -78 °C under argon atmosphere, and stirred for 10 min at rt. The reaction mixture was cooledto -78 °C and added MeI (3.9 ml, 62.6 mmol, 1.2 eq) dropwise at -78 °C. The mixture was gradually warmed to rt and stirred for 18 h. The mixture was quenched with MeOH, then concentrated in vacuo. The residue was dissolved with CH2Cl2 and the solution was filtered through a pad of Celite to afford the crude product, which was purified by silica gel chromatography (20:1 CHCl3 / MeOH) to afford 15 (5.58 g, 99percent) as a yellow oil. 1H NMR (500 MHz, CDCl3) δ 3.79 (s, 3H), 7.53 (s, 1H), 7.60 (s, 1H), 9.88 (s, 1H)
53% With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 1.5 h; To a cooled (0 °C) solution of NaH (60 percent oil dispersion, 832 mg, 20.8 mmol) and 4-formylimidazole (2.0 g, 20.8 mmol) in dry DMF (30 mL) was added dropwise iodomethane (1.5 mL, 23.0 mmol). The reaction mixture was stirred at rt for 1.5 hr. After quenching the reaction with water, the solvent was removed by evaporation. The residue was dissolved in water and extracted with CHCl3. The extracts were dried over MgSO4 and concentrated by evaporation. The residue was purified by flash column chromatography on SiO2 (CHCl3 → CHCl3 : MeOH = 100 : 1 → 50 : 1 → 10 : 1) to give 36 (1.2 g, 53 percent) as a pale yellow solid.
34% With sodium hydride In N,N-dimethyl-formamide at 0 - 20℃; for 2 h; To a stirring solution of NaH (1.25 g, 52.1 mmol) in DMF (65 mL) was added SM1 (5 g, 52.1 mmol) followed by iodomethane (8.13 g, 57.3 mmol) at 0 °C. Thereaction mixture was stirred at room temperature for 2 h. The reaction mixture was diluted with water and extracted with DCM. Combined organic extracts were dried over anhydrous Na2SO4 and concentrated under reduced pressure to obtain crude product, which was purified by silica gel column chromatography eluting with 5percent MeOH/ DCM to compound 1(1.95 g, 34percent) as a yellow solid. LC-MS: m/z = 111[(M+1)].
Reference: [1] Synlett, 2016, vol. 27, # 19, p. 2734 - 2736
[2] Bulletin of the Chemical Society of Japan, 2015, vol. 88, # 6, p. 784 - 791
[3] Patent: WO2016/44777, 2016, A1, . Location in patent: Page/Page column 61
[4] Patent: WO2003/87088, 2003, A2, . Location in patent: Page/Page column 28
  • 22
  • [ 3034-50-2 ]
  • [ 74-88-4 ]
  • [ 39021-62-0 ]
  • [ 17289-26-8 ]
Reference: [1] Organic and Biomolecular Chemistry, 2005, vol. 3, # 1, p. 118 - 122
[2] Chemistry - A European Journal, 2009, vol. 15, # 14, p. 3560 - 3566
  • 23
  • [ 3034-50-2 ]
  • [ 74-88-4 ]
  • [ 17289-26-8 ]
Reference: [1] Combinatorial Chemistry and High Throughput Screening, 2011, vol. 14, # 7, p. 570 - 582
  • 24
  • [ 3034-50-2 ]
  • [ 74-88-4 ]
  • [ 39021-62-0 ]
  • [ 17289-26-8 ]
Reference: [1] Journal of Heterocyclic Chemistry, 2007, vol. 44, # 6, p. 1445 - 1451
  • 25
  • [ 76-83-5 ]
  • [ 3034-50-2 ]
  • [ 33016-47-6 ]
YieldReaction ConditionsOperation in experiment
100% With triethylamine In N,N-dimethyl-formamide at 0 - 20℃; Example 33: 1 -trityl-1 H-imidazole-4-carbaldehydeTo a solution of 1W-imidazole-4-carbaldehyde {30.0 g, 0.30 mol) in DMF (200 mL) was added Et3N (70 mL, 0.375 mol) under ice bath, and then Trt-CI (105 g, 0.375 mol) was added in portions and the mixture stirred at RT overnight. The mixture was evaporated in vacuo and the residue was washed with anhydrous Et2O (4 x 50 mL), and the resulting precipitate was dried to yield the title compound (100 g, 100percent) as a yellow solid.
98% With triethylamine In dichloromethane at 0 - 20℃; [2372] To a stirred solution of 4(5)-imidazolecarboxaldehyde (20.0 g, 0.208 mmol) in CH2Cl2 (200 mL), was added Et3N (29.0 mL, 0.208 mmol). The solution was then cooled down at 0° C., followed by addition of triphenylmethylchloride (52.8 g, 0.18 mmol) at 0° C. The resulting solution was stirred at room temperature overnight and then washed it with brine, water and concentrated to dryness to give a white solid (63.0 g, 98percent yield, MH+=339.1)
96% With triethylamine In acetonitrile Dry triethylamine (12.6 mL, 90.0 mmol) was added drop wise over two hours to a slurry of (l,3)-H-imidazole-4-carbaldehyde (5.0 g, 52 mmol) and trityl chloride (16.0 g, 57.0 mmol) in acetonitrile (170 mL). After complete addition of the triethylamine, the resulting solution was stirred overnight and then hexane (16.6 mL) and water (170 mL) were added. After stirring for an additional 30 minutes, the resulting solid was collected and dried overnight under vacuum to provide the title compound as a white solid (16.8 g, 96percent). 1H NMR (400 MHz, CDCl3): δ 9.81 (s, IH), EPO <DP n="24"/>7.54 (s, IH), 7.46 (s, IH), 7.29 (m, 10H), 7.04 (m, 5H). 13C NMR (100 MHz, CDCl3): δ 186.9, 141.9, 141.2, 141.0, 130.0, 129.0, 128.9, 127.2, 76.7.
95% With alkaline condition In acetonitrile at 20℃; for 2 h; To a mixture of 10 (1.03 g, 10.7 mmol) and TrCl (3.29 g, 11.8 mmol, 1.1 eq) in MeCN (45 mL) was added Et3N (2.5 mL, 18.0 mmol, 1.7 eq) at rt. After stirring for 2 h, hexane (3 mL) and H2O (40 mL) were added and the mixture was filtered. The resultant cake was washed with water three times and dried in a house vacuumoven at 50 °C to afford 18 (3.42 g, 95percent) as a white powder.1H NMR (500 MHz, CDCl3) δ 7.10-7.13 (m, 5H), 7.35-7.38 (m, 10H), 7.53 (d, J = 1.1 Hz, 1H), 7.61 (d, J =1.7 Hz, 1H), 9.88 (s, 1H)
78% With triethylamine; citric acid In <i>N</i>-methyl-acetamide; ethyl acetate Synthesis of 1-Trityl-1H-imidazole-4-carbaldehyde STR49
To dimethylformamide (100 mL) was added imidazole-4-carboxaldehyde (10 g, 0.104 mol, Aldrich Chemical Corp.) and triethylamine (20.5 mL, 0.147 mol).
A solution of trityl chloride (40 g, 0.143 mol) in dimethylformamide (300 mL) was added, followed by stirring at 25° C. for 6 hours.
The solvent was removed in vacuo, and the residue was dissolved in ethyl acetate (1.5 L) and 1N citric acid (350 mL).
The phases were separated, and the organic phase was washed with brine, dried over anhydrous magnesium sulfate, and filtered.
Concentration of the solution in vacuo gave a white solid, 27.59 g, 78percent yield. NMR was consistent with structure. MS: APCI: M-1: 337.2 (M: 338.41).
67% With triethylamine In N,N-dimethyl-formamide at 20℃; for 18 h; Intermediate 18:l-trityl-lH-imidazole-4-carbaldehyde[00417 ] Triethylamine (3.05 ml, 21.86 mmol) was added to a solution of lH-imidazole-4- carbaldehyde (2 g, 20.82 mmol) and triphenylmethyl chloride (5.80 g, 20.82 mmol) in N5N- dimethylformamide (20 ml). The reaction mixture was stirred at room temperature for 18 hours. The crude mixture was concentrated in vacuo and partitioned between ethyl acetate and water. The organic phase was washed dried over sodium sulfate, filtered and concentrated in vacuo. The residue was recrystallised from dichloromethane and hexanes to afford the title compound as a cream solid (4.7 g, 67percent yield).[00418] 1H NMR (DMSO-d6, 400 MHz) δ 7.10-7.16 (6H, m), 7.36-7.57 (9H, m), 7.63 (IH, s), 7.64 (IH, s), 9.91 (IH, s).
65% With triethylamine In ISOPROPYLAMIDE at 25℃; for 24 h; Reference Example 11 To 4 (5) -formylimidazole (2 g, 20.8 mmol) were added D Ac (30 mL) and triethylamine (3.5 mL, 25.0 mmol, 1.2 equivalents), and then trityl chloride (4.06 g, 14.6 mmol, 0.7 equivalents) was added thereto at room temperature. The mixture was stirred at room temperature for 24 hr, and to the reaction mixture was added water (60 mL) at room temperature, and the mixture was stirred at room temperature for 2 hr. The crystals werecollected by filtration, washed with water, and vacuum-dried(50°C) to a constant amount to give a crude compound (4.6 g) . To the crude compound (0.2 g) was added methanol (1 mL) , and the. mixture was stirred at room temperature for 2 hr. The crystals were collected by filtration, was washed withmethanol (0.2 mL) , and vacuum-dried (50°C) to a constant amount to give l-trityl-4-formyl-lH-imidazole (0.14 g) . yield 65percent.
10 g With triethylamine In N,N-dimethyl-formamide at 0 - 35℃; A)
1-trityl-1H-imidazol-4-carbaldehyde
A mixture of 1H-imidazol-4-carbaldehyde (3.00 g), triethylamine (7.00 g) and N,N-dimethylformamide (40 mL) was cooled to 0°C, trityl chloride (10.5 g) was added thereto.
The reaction mixture was stirred at room temperature for 18 hr, water was added thereto, and the solid was collected by filtration.
The obtained solid was washed with water and diethyl ether to give the title compound (10.0 g).
1H NMR (400 MHz, DMSO-d6) δ 7.11-7.14 (6H, m), 7.40-7.48 (9H, m), 7.67 (1H, d, J = 0.8 Hz), 7.80 (1H, d, J = 1.2 Hz), 9.23 (1H, s).

Reference: [1] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 23, p. 7993 - 8002
[2] Patent: WO2008/4096, 2008, A1, . Location in patent: Page/Page column 79
[3] Journal of Medicinal Chemistry, 2002, vol. 45, # 1, p. 177 - 188
[4] European Journal of Organic Chemistry, 2015, vol. 2015, # 18, p. 3957 - 3962
[5] Patent: US2004/122018, 2004, A1, . Location in patent: Page 317
[6] Organic and Biomolecular Chemistry, 2011, vol. 9, # 7, p. 2274 - 2278
[7] Journal of Medicinal Chemistry, 2011, vol. 54, # 6, p. 1693 - 1703
[8] Angewandte Chemie - International Edition, 2005, vol. 44, # 31, p. 4903 - 4906
[9] Journal of Medicinal Chemistry, 2006, vol. 49, # 19, p. 5710 - 5727
[10] Patent: WO2006/102159, 2006, A2, . Location in patent: Page/Page column 21; 22
[11] Chemistry - A European Journal, 2006, vol. 12, # 16, p. 4321 - 4332
[12] Synlett, 2016, vol. 27, # 19, p. 2734 - 2736
[13] Chemical Communications, 2011, vol. 47, # 48, p. 12855 - 12857
[14] Patent: US6143766, 2000, A,
[15] Journal of Medicinal Chemistry, 2010, vol. 53, # 4, p. 1712 - 1725
[16] Patent: WO2008/94992, 2008, A2, . Location in patent: Page/Page column 188
[17] Tetrahedron Letters, 2006, vol. 47, # 8, p. 1253 - 1255
[18] Patent: WO2012/173280, 2012, A1, . Location in patent: Page/Page column 35-36
[19] Patent: US2003/199522, 2003, A1,
[20] Patent: US2002/82272, 2002, A1,
[21] Patent: WO2010/52256, 2010, A1, . Location in patent: Page/Page column 37
[22] Patent: WO2010/52255, 2010, A1, . Location in patent: Page/Page column 68
[23] Patent: WO2006/23720, 2006, A2, . Location in patent: Page/Page column 48
[24] Patent: US2007/49616, 2007, A1, . Location in patent: Page/Page column 29
[25] Patent: EP2848618, 2015, A1, . Location in patent: Paragraph 0816
[26] ChemMedChem, 2018, vol. 13, # 8, p. 842 - 851
  • 26
  • [ 3034-50-2 ]
  • [ 76-83-5 ]
  • [ 33016-47-6 ]
YieldReaction ConditionsOperation in experiment
98% at 0 - 20℃; [1815] To a stirred solution of 4(5)-imidazolecarboxaldehyde (20.0 g, 0.208 mmol) in CH2Cl2 (200 mL), was added Et3N (29.0 mL, 0.208 mmol). The solution was then cooled down at 0° C., followed by addition of triphenylmethylchloride (52.8 g, 0.18 mmol) at 0° C. The resulting solution was stirred at room temperature overnight and then washed it with brine, water and concentrated to dryness to give a white solid (63.0 g, 98percent yield, MH+=339.1)
94% With triethylamine In acetonitrile at 20℃; for 20.3333 h; To a 1L three-necked round-bottomed flask with an addition funnel was added 3H-imidazole-4-carbaldehyde (4, 12 g, 0.125 mol) trityl chloride (38.3 g, 0.137 mol) and acetonitrile (400 mL). The mixture was stirred at rt to give a slurry. Triethylamine (30 mL, 0.215 mol) was added drop wise over 20 min. After the addition was complete, the reaction mixture was stirred at rt for 20 h. Hexane (40 mL) and water (400mL) were added. The slurry was stirred for 30 min and filtered. The cake was washed with water (3 × 100 mL) and dried in a vacuum oven at 50 °C for 20 h to give 5 as a white solid (39.8 g, 94percent).
Reference: [1] Patent: US2003/229099, 2003, A1, . Location in patent: Page 269
[2] Journal of Medicinal Chemistry, 2010, vol. 53, # 10, p. 3887 - 3898
[3] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 23, p. 6492 - 6499
[4] Organic Process Research and Development, 2000, vol. 4, # 6, p. 613 - 614
[5] Journal of Medicinal Chemistry, 2007, vol. 50, # 19, p. 4585 - 4605
[6] Journal of Medicinal Chemistry, 2009, vol. 52, # 12, p. 3703 - 3715
  • 27
  • [ 3034-50-2 ]
  • [ 66247-84-5 ]
YieldReaction ConditionsOperation in experiment
100%
Stage #1: With ammonia In methanol at 40℃; for 0.5 h;
Stage #2: With hydrogen In methanol at 40 - 50℃; for 28 h;
Stage #3: With hydrogenchloride In methanol; diethyl ether
12.0 g (124 mmol) 4-formyl-imidazole are placed together with 750 mg Raney nickel in 1000 ml of methanolic ammonia solution and shaken at 40° C. for 30 min. Then the mixture is hydrogenated in a Parr apparatus under a hydrogen atmosphere at 5 bars pressure at 40° C. for 14 h. Another 750 mg Raney nickel are then added and the mixture is again hydrogenated at 50° C. under a hydrogen atmosphere at 5 bars pressure for 14 h. The mixture is filtered, evaporated down i. vac., and in each case methanol, toluene and ethanol are added to the residue and it is again evaporated down completely i. vac. The residue is combined with ethereal hydrochloric acid in methanol and evaporated down completely i. vac. The residue is in each case combined with methanol and dichloromethane and evaporated down completely i. vac.Yield: 21.2 g (quant.)Rt value: 0.49 min (D)C4H7N3*2 HCl (170.04/97.12)Mass spectrum: (M+H)+=98
Reference: [1] Patent: US2008/51578, 2008, A1, . Location in patent: Page/Page column 34
  • 28
  • [ 106-94-5 ]
  • [ 3034-50-2 ]
  • [ 199192-04-6 ]
Reference: [1] Patent: US2003/199522, 2003, A1,
[2] Patent: US2002/147229, 2002, A1,
  • 29
  • [ 106-94-5 ]
  • [ 3034-50-2 ]
  • [ 199192-04-6 ]
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 24, p. 6095 - 6103
  • 30
  • [ 109-65-9 ]
  • [ 3034-50-2 ]
  • [ 199192-04-6 ]
Reference: [1] Patent: US2003/199522, 2003, A1,
  • 31
  • [ 14508-49-7 ]
  • [ 3034-50-2 ]
  • [ 503176-43-0 ]
Reference: [1] Patent: US2003/125267, 2003, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 3034-50-2 ]

Aldehydes

Chemical Structure| 1914148-58-5

[ 1914148-58-5 ]

1-Ethyl-1H-imidazole-5-carbaldehyde hydrochloride

Similarity: 0.86

Chemical Structure| 68282-53-1

[ 68282-53-1 ]

5-Methyl-1H-imidazole-4-carbaldehyde

Similarity: 0.82

Chemical Structure| 86027-00-1

[ 86027-00-1 ]

4,5-Dimethyl-1H-imidazole formate

Similarity: 0.73

Chemical Structure| 68282-52-0

[ 68282-52-0 ]

2,4-Dimethyl-1H-imidazole-5-carbaldehyde

Similarity: 0.73

Chemical Structure| 17289-26-8

[ 17289-26-8 ]

1-Methyl-1H-imidazole-4-carbaldehyde

Similarity: 0.71

Related Parent Nucleus of
[ 3034-50-2 ]

Imidazoles

Chemical Structure| 1914148-58-5

[ 1914148-58-5 ]

1-Ethyl-1H-imidazole-5-carbaldehyde hydrochloride

Similarity: 0.86

Chemical Structure| 68282-53-1

[ 68282-53-1 ]

5-Methyl-1H-imidazole-4-carbaldehyde

Similarity: 0.82

Chemical Structure| 1072-84-0

[ 1072-84-0 ]

1H-Imidazole-4-carboxylic acid

Similarity: 0.77

Chemical Structure| 20970-50-7

[ 20970-50-7 ]

1-(1-Methyl-1H-imidazol-5-yl)ethanone

Similarity: 0.74

Chemical Structure| 86027-00-1

[ 86027-00-1 ]

4,5-Dimethyl-1H-imidazole formate

Similarity: 0.73